UC BRAID program leaders, from left, are Gary S. Firestein, MD (UC San Diego), Dan M. Cooper, MD (UC Irvine), Lars Berglund, MD, PhD (UC Davis), Clay Johnston, MD, PhD (UCSF), and Steven M. Dubinett, MD (UCLA).
October 2, 2013 - UC San Diego – with Dr. Gary Firestein, Director of CTRI, Sharon Franks from Research Affairs, and Phil Bourne from the School of Pharmacy and Pharmaceutical Sciences at the forefront – is part of a UC Medical Campus consortium awarded $12 million by the NIH's National Heart, Lung and Blood Institute to create a Center for Accelerated Innovation (CAI). UC San Diego joins UC Davis, UC Irvine, UCLA and UC San Francisco to make up the UC consortium. The CAI will be closely integrated with the translational research institutes and centers on the five campuses funded by Clinical and Translational Science Awards (CTSA), which includes CTRI.
"The launch of this program is a remarkable example of inter-institutional collaboration," said Dr. Gary Firestein, director of UC San Diego's CTRI and chair of the UC Biomedical Research Acceleration, Integration and Development (UC BRAID). "The leaders of engineering, business and medical schools across the five campuses developed a shared vision and worked with UC BRAID to create an extraordinary proposal. The new resources will dramatically accelerate the development of novel diagnostics, therapies and devices discovered at the University of California."
The new UC center is one of three inaugural, multi-institution CAIs designated. UC BRAID, which links the five UC medical campuses to facilitate contracting, data sharing, regulatory oversight and other activities, will oversee the new center.
UC San Diego release